Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger G Pertwee

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
British Journal of Pharmacology|October 6, 2005
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonistAdèle Thomas, Lesley A Stevenson, Kerrie N Wease, et al.
Journal of Neuroimmunology|November 27, 2007
Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosisJ Ludovic Croxford, Gareth Pryce, Samuel J Jackson, et al.
Bioorganic & Medicinal Chemistry|October 11, 2021
Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressureSumanta Garai, Peter C Schaffer, Robert B Laprairie, et al.
Behavioural Pharmacology|October 31, 2014
Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459Anushka V Goonawardena, Andrea Plano, Lianne Robinson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2021
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulatorsFrancesca Gado, Costanza Ceni, Rebecca Ferrisi, et al.
Central Nervous System Agents in Medicinal Chemistry|September 25, 2020
Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary StudyJosé Carlos Pastrana-Trejo, Fátima Duarte-Aké, Rosa Us-Camas, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 5, 2019
Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasionIain Brown, Jisun Lee, Alan A Sneddon, et al.
Carcinogenesis|July 28, 2010
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell linesIain Brown, Maria G Cascio, Klaus W J Wahle, et al.
European Journal of Medicinal Chemistry|July 19, 2020
PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptorSerena Meini, Francesca Gado, Lesley A Stevenson, et al.
British Journal of Pharmacology|October 24, 2017
Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT<sub>1A</sub> receptor-mediated suppression of nausea and anxiety in ratsRoger G Pertwee, Erin M Rock, Kelsey Guenther, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
British Journal of Pharmacology|October 6, 2005
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonistAdèle Thomas, Lesley A Stevenson, Kerrie N Wease, et al.
Journal of Neuroimmunology|November 27, 2007
Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosisJ Ludovic Croxford, Gareth Pryce, Samuel J Jackson, et al.
Bioorganic & Medicinal Chemistry|October 11, 2021
Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressureSumanta Garai, Peter C Schaffer, Robert B Laprairie, et al.
Behavioural Pharmacology|October 31, 2014
Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459Anushka V Goonawardena, Andrea Plano, Lianne Robinson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2021
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulatorsFrancesca Gado, Costanza Ceni, Rebecca Ferrisi, et al.
Central Nervous System Agents in Medicinal Chemistry|September 25, 2020
Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary StudyJosé Carlos Pastrana-Trejo, Fátima Duarte-Aké, Rosa Us-Camas, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 5, 2019
Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasionIain Brown, Jisun Lee, Alan A Sneddon, et al.
Carcinogenesis|July 28, 2010
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell linesIain Brown, Maria G Cascio, Klaus W J Wahle, et al.
European Journal of Medicinal Chemistry|July 19, 2020
PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptorSerena Meini, Francesca Gado, Lesley A Stevenson, et al.
British Journal of Pharmacology|October 24, 2017
Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT<sub>1A</sub> receptor-mediated suppression of nausea and anxiety in ratsRoger G Pertwee, Erin M Rock, Kelsey Guenther, et al.
Pageof 11